To better understand the basic mechanisms of myeloma progression in patients with SMM, most of the genetic studies have focused on investigating CD138+ PC characteristics such as chromosomal aberrations (14), gene expression profiling (15), whole-exome sequencing of clonal PC (16–18). The gene discussed is SDC1; the disease is pachyonychia congenita.